James Merson

Janssen (United States) — United States

Immunology and Microbiology · Life Sciences

19h-index1.9kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(9), Influenza Virus Research Studies(7), HIV/AIDS drug development and treatment(6), Respiratory viral infections research(5), Immunotherapy and Immune Responses(4)

Publications32 total

Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors
Clinical Immunology·2023· 7 citedOpen Access
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors
2023· 1 citedOpen Access
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
Cancer Immunology Immunotherapy·2022· 7 citedOpen Access
Reduction of immune inhibitory myeloid derived suppressor cells by low dose sunitinib combined with a cancer vaccine to provide therapeutic benefit to tumor-bearing mice.
Journal of Clinical Oncology·2017· 2 cited
In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity
Vaccine·2016· 11 cited
The effect of preexisting anti-carrier immunity on subsequent responses to CRM<sub>197</sub>or Qb-VLP conjugate vaccines
Immunopharmacology and Immunotoxicology·2016· 37 cited
Immunogenicity of a peptide‐based anti‐IgE conjugate vaccine in non‐human primates
Immunity Inflammation and Disease·2016· 9 citedOpen Access
A Phase 1 First-in-Human Study (B4901001) Evaluating a Novel Anti-IgE Vaccine in Adult Subjects with Allergic Rhinitis
Journal of Allergy and Clinical Immunology·2016· 2 cited
Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants through Activation of TLR7
Vaccines·2016· 31 citedOpen Access
Anti-nicotine vaccines: Comparison of adjuvanted CRM 197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates
International Immunopharmacology·2015· 42 cited
Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates
International Immunopharmacology·2015· 38 cited
Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients
Blood·2014· 1 cited
Selection of a Novel Anti-Nicotine Vaccine: Influence of Antigen Design on Antibody Function in Mice
PLoS ONE·2013· 80 citedOpen Access
Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus
The Journal of Infectious Diseases·2013· 16 citedOpen Access
Enhancing immunogenicity of a 3′aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates
International Immunopharmacology·2013· 57 cited
Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic
The Journal of Immunology·2012· 54 citedOpen Access
Will biomedical innovation change the future of healthcare?
Drug Discovery Today·2009· 6 cited
96-Well solid-phase extraction: a brief history of its development
Journal of Chromatography B·2004· 41 cited
Inhibition of CCR5-Dependent HIV-1 Infection by Hairpin Ribozyme Gene Therapy against CC-Chemokine Receptor 5
Virology·2000· 61 cited
Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.
Journal of General Virology·1999· 90 cited
page 1 of 2Next →

Frequent Co-authors

Heather L. Davis(8), Michael J. McCluskie(8), Ningli Zhang(6), David R. Stead(5), Jennifer M. Thorn(5), Risini D. Weeratna(5), Michelle Benoit(4), Dennis E. Danley(3), Kieran F. Geoghegan(3), Peter Hobart(3), Willard Lew(3), David Gervais(3), In-Jeong Kim(3), Brian Champion(3), Risto Lapatto(2), Andrew M. Hemmings(2), John P. Overington(2), Andrew F. Wilderspin(2), Stephen Wood(2), Peter J. Whittle(2)